Prenetics Global (Prenetics Global) Claims Ratio % : 66.60% (As of Jun. 2019)

View and export this data going back to 2022. Start your Free Trial

What is Prenetics Global Claims Ratio %?

Claims Ratio % is the percentage of claims costs incurred in relation to the premiums earned.

Prenetics Global's Claims Ratio % for the quarter that ended in Jun. 2019 was 66.60% , which is higher than 65.50% for the pervious quarter ended in Jun. 2018.

The historical rank and industry rank for Prenetics Global's Claims Ratio % or its related term are showing as below:

PRE's Claims Ratio % is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median:
* Ranked among companies with meaningful Claims Ratio % only.

Prenetics Global Claims Ratio % Historical Data

The historical data trend for Prenetics Global's Claims Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prenetics Global Claims Ratio % Chart

Prenetics GlobalQuarterly Data

Trend

Jun17

Sep17

Mar18

Jun18

Jun19

Claims Ratio %

Get a 7-Day Free Trial

Expense Ratio %

Get a 7-Day Free Trial

Combined Ratio %

Get a 7-Day Free Trial

Competitive Comparison of Prenetics Global's Claims Ratio %

For the Diagnostics & Research subindustry, Prenetics Global's Claims Ratio %, along with its competitors' market caps and Claims Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prenetics Global (NAS:PRE) Claims Ratio % Calculation

Claims Ratio % is calculated as

Claims Ratio %

Total Claims

Total Premiums Earned

100%

Prenetics Global (NAS:PRE) Claims Ratio % Explanation

Claims Ratio % the percentage of claims costs incurred in relation to the premiums earned during the period. It is the equivalent of gross profit margin for an insurance company.

It's important to note that insurance is the business of managing risks and, to do that well, the insurer needs a thorough understanding of the incurred claims ratio. If the value is higher than expected or above established norms, then further investigation is required to figure out why that is (eg: fraud). If it is lower than expected, it could indicate irrelevant products or difficulties in claiming, possibly affecting customer satisfaction.

Prenetics Global Claims Ratio % Related Terms

Thank you for viewing the detailed overview of Prenetics Global's Claims Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Prenetics Global (Prenetics Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prenetics Global Ltd (NAS:PRE) » Definitions » Claims Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong, HKG

Website

https://www.prenetics.com

Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.